Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2-inhibitor, compared to naproxen in patients with arthritis. - Goldstein,J.L.; Correa,P.; Zhao,W.W. (Am J Gastroenterol, 2001)